Dr. Sarfo-Kantanka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Baylor Scott & White Center For Diagnostic Medicine – Temple
1605 S 31st St
Temple, TX 76508
Summary
- Multifaceted, well trained, innovative and highly talented Internal Medicine Physician with unwavering commitment to high quality and value-based patient care. Extensive background working with veterans, underprivileged and medically underserved populations. A visionary in advancing goals through clinical research and grow within the dynamic needs of any healthcare system.
Education & Training
Meharry Medical CollegeClass of 2016
University of OregonBS, Biology, Society of College Scholars, 2006 - 2011
Certifications & Licensure
TX State Medical License 2021 - 2026
TN State Medical License 2020 - 2024
Publications & Presentations
PubMed
- 30 citationsPanobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparibAndrew J. Wilson, Kofi Sarfo-Kantanka, Toby Barrack, Alexandra Steck, Jeanette Saskowski
Gynecologic Oncology. 2016-10-01
Journal Articles
- Hypofractionated Radiation Therapy in the Treatment of Anaplastic Thyroid CancerM.J. Stavas, E. Shinohara, K. Sarfo-Kantanka and A. Cmelak, International Journal of Radiation Oncology, Biology, Physics, 1/2/2014
Abstracts/Posters
- A Comparison of Helical Tomotherapy with Standard Radiotherapy Treatment Planning (AP/PA) in Patients with Wilms' Tumor and Ewing's SarcomaKofi Sarfo-Kantanka, Richard Crilly and Logan Moll, Proceedings of the Eleventh Annual AACR International Conference on Frontiers in Cancer Prevention Research / Cancer Prev Res, Anaheim, CA, 10/16/2012
Grant Support
- Meharry-VICC-TSU Cancer PartnershipNational Cancer Institute (NCI)2015–2016
Research History
- Visiting Research Medical Student at Vanderbilt University Medical CenterI was part of the team that performed a retrospective series investigating the effectiveness and tolerability of hypofractionated radiation therapy in treatment of Anaplastic Thyroid Cancer (ATC). We demonstrated the safety and feasibility of hypofractionated radiotherapy in the treatment of ATC.2012 - 2013
- Visiting Scientist at Oregon Health and Science UniversityWe conducted a comparison study of two radiotherapy treatment planning and delivery approaches in patients with Wilm's tumor and Ewing's sarcoma. It was observed that the helical tomotherapy is better for treating volumes that minimize dose to normal tissues and supply uniform doses.2012 - 2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
